SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-052158
Filing Date
2018-10-02
Accepted
2018-10-02 19:20:08
Documents
2
Period of Report
2018-09-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv503994_3.html 3  
1 OWNERSHIP DOCUMENT tv503994_3.xml 3 1654
2 EXHIBIT 24 tv503994_ex24.htm EX-24 2755
  Complete submission text file 0001144204-18-052158.txt   5891
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 9620 MEDICAL CENTER DRIVE, SUITE 300 ROCKVILLE MD 20850
Business Address
Chi George (Reporting) CIK: 0001753434 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-20713 | Film No.: 181103207